Induction of oocyte maturation using gonadotropin releasing hormone (GnRH) agonist instead of human chorionic gonadotropin (hCG) has been shown to be effective in preventing the development of OHSS [1–3]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.